| Literature DB >> 36128445 |
Cristiano Spadaccio1, Angelo Pisani2, Antonio Salsano3,4, Antonio Nenna5, Alexander Fardman6,7, David D'Alessandro1, Francesco Santini3,4, Mario F L Gaudino8, Thoralf M Sundt1, David Rose9.
Abstract
This study aims to compare treatments and outcomes of mechanical complications of acute myocardial infarction (MI) during the Covid-19 and in the pre-Covid-19 era. Electronic databases have been searched for MI mechanical complications during the Covid-19 era and in the previous period from January 1998 to January 2020 (pre-Covid-19 era), until October 2021. To perform a quantitative analysis of non-comparative series, a meta-analysis of proportion has been conducted. Early mortality after surgical treatment was 15.0% while it was significantly higher after conservative treatment (62.4%) (P = 0.026). Early mortality after surgical treatment was seemingly higher in the pre-Covid-19 era but the difference did not reach statistical significance (15.0% vs 38.9%; P = 0.13). Mortality in patients treated conservatively, or turned down for surgery, was lower during the Covid-19 pandemic (62.4% vs 97.7%; P = 0.001). The crude mean prevalence of the use rate of conservative or surgical treatment across the studies during Covid-19 and in the pre-Covid-19 era was comparable. The current increased incidence of MI mechanical complications might be a consequence of delayed presentation or restricted access to hospital facilities. Despite the general negative impact of Covid-19 on cardiac surgery volumes and outcomes and the apparent increase of the incidence of MI complications, the outcomes of their surgical and clinical treatment seem not to have been affected during the pandemic.Entities:
Keywords: Covid-19; mechanical complications; myocardial infarction
Year: 2022 PMID: 36128445 PMCID: PMC9449689 DOI: 10.1515/med-2022-0545
Source DB: PubMed Journal: Open Med (Wars)
Treatments and outcomes of mechanical complications of MI considering Covid-19 pandemic
| Results of the metanalysis | Pooled results | Treatments/timing |
| Egger’s test | |
|---|---|---|---|---|---|
| Early mortality during Covid-19 pandemic, surgery vs no surgery | 67 patients | Surgery | No surgery |
|
|
| 31% (13–52%) | 22 studies, 38 patients | 13 studies, 29 patients | |||
|
| 15% (1–37%), | 62% (27–93%), | |||
| Early mortality after surgery, before vs during Covid-19 pandemic | 8,504 patients | Surgery before Covid-19 | Surgery during Covid-19 |
|
|
| 35% (31–40%) | 47 studies, 8,466 patients | 22 studies, 38 patients | |||
|
| 39% (35–43%), | 15% (1–37%), | |||
| Early mortality after conservative treatment, before vs during Covid-19 pandemic | 210 patients | No surgery before Covid-19 | No surgery during Covid-19 |
|
|
| 95% (80–100%) | 8 studies, 181 patients | 13 studies, 29 patients | |||
|
| 98% (94–100%), | 62% (27–93%), | |||
To perform a quantitative analysis of non-comparative series, a meta-analysis of proportion has been conducted. To draw statistical inferences from heterogeneous studies, we employed non-iterative estimate of the inter-study variance component based on a random effects model, considering that statistical heterogeneity is believed to be due to clinical diversity. Double arcsine transformations have been applied to the observed proportions identified across a collection of studies to make the transformed proportions follow a normal distribution. Multiple meta-regression with the Knapp–Hartung adjustment has been used to test the influence of the publication date and Covid-19 on early mortality.